China Diabetes Impact Study is funded by IDF and technically supported by Division of Diabetes Translation of CDC. It is a follow-up study of China National Diabetes and Metabolic Disorder Study. A total of 12 study sites participated in the China Diabetes Impact Study. I am the national program coordinator and the investigator of Beijing study site. All study participants with DM, NDM and IGR were interviewed and collected information about their health care service use, medical expenditure, etc. 

Research Interest: Molecular Pharmacology, Chinese Medicines and Diabetes Mellitus, Effects and Mechanism of Natural Products on Cardio-Cerebrovascular Disease.

Research Interest: Dietetics Applied to Bariatric Ssurgery; Clinical Impact of Bariatric Surgery on Patient’s Body Composition (Fat Mass and Fat-Free Mass) and Resting Metabolic Rate; Pre- and Post-Operative Treatment of Micronutrient Deficiencies in Patients that Underwent Bariatric Surgery.

Research Interest: Application of Multiple Linear and Logistic Regression Models, Applied Longitudinal Data Analysis, Generalized Linear and Non-Linear Mixed Models, and Survival Analysis; Epidemiology of Chronic Diseases Including Alcohol use Disorders and Drug Abuse, Alzheimer’s Disease, Cancer, Obesity and Diabetes, Heart Disease and Stroke; Genetic Epidemiology of Complex Diseases Including Alcohol Dependence And Comorbidity, Obesity, Diabetes and Related Conditions, Depression and Schizophrenia.

Research Interest: Clinical Cardiology; Clinical Pharmacology; Cardiovascular Physiology; Arterial Hypertension; Blood Pressure Monitoring; Telemedicine.

2 Parati G, Ravogli A, Bragato R, OMBONI S, Mutti E, Mancia G. Clinical and hemodynamic effects of celiprolol in essential hypertension. J Cardiovasc Pharmacol 1989;7:S14-21.
3 Mancia G, Groppelli A, Casadei R, OMBONI S, Mutti E, Parati G. Cardiovascular effects of smoking. Clin Exp Hypertens A 1990;5:917-29.
4 Parati G, Castiglioni P, Di Rienzo M, OMBONI S, Pedotti A, Mancia G. Sequential spectral analysis of 24-hour blood pressure and pulse interval in humans. Hypertension 1990;4:414-21.
5 Groppelli A, OMBONI S, Parati G, Mancia G. Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition. J Hypertens Suppl 1990;5:S35-40.
6 Mutti E, Trazzi S, OMBONI S, Parati G, Mancia G. Effect of placebo on 24-h non-invasive ambulatory blood pressure. J Hypertens 1991;4:361-4.
7 Parati G, Trazzi S, Ravogli A, Casadei R, OMBONI S, Mancia G. Methodological problems in evaluation of cardiovascular effects of stress in humans. Hypertension 1991;4 Suppl:III50-5.
8 Groppelli A, OMBONI S, Ravogli A, Villani A, Parati G, Mancia G. Validation of the SpaceLabs 90202 and 90207 devices for ambulatory blood pressure monitoring by comparison with intra-arterial resting and ambulatory measurements. J Hypertens Suppl 1991;6:S334-5.
9 Trazzi S, OMBONI S, Mutti E, Parati G, Zanchetti A, Mancia G. Acute modulation of arterial compliance in mild essential hypertension. J Hypertens Suppl 1991;6:S110-1.
10 Zito M, Parati G, OMBONI S, Cervone C, Ulian L, D'Aviero M, Abate G, Mancia G. Effect of ageing on blood pressure variability. J Hypertens Suppl 1991;6:S328-9.
11 OMBONI S, Ravogli A, Parati G, Zanchetti A, Mancia G. Prognostic value of ambulatory blood pressure monitoring. J Hypertens Suppl 1991;3:S25-8.
12 Parati G, Groppelli A, OMBONI S, Trazzi S, Frattola A, Mancia G. Testing the accuracy of blood pressure monitoring devices in ambulatory conditions. J Hypertens Suppl 1991;8:S7-9.
13 Di Rienzo M, Parati G, Castiglioni P, OMBONI S, Ferrari AU, Ramirez AJ, Pedotti A, Mancia G. Role of sinoaortic afferents in modulating BP and pulse-interval spectral characteristics in unanesthetized cats. Am J Physiol 1991;6 Pt 2:H1811-8.
14 Groppelli A, Giorgi DM, OMBONI S, Parati G, Mancia G. Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992;5:495-9.
15 Giannattasio C, Cattaneo BM, OMBONI S, Seravalle G, Bolla G, Turolo L, Morganti A, Grassi G, Zanchetti A, Mancia G. Sympathomoderating influence of benazepril in essential hypertension. J Hypertens 1992;4:373-8.
16 Mancia G, OMBONI S, Parati G, Trazzi S. Twenty-four hour blood pressure monitoring and end-organ damage. Blood Press Suppl 1992;1:38-41.
17 Mancia G, Frattola A, OMBONI S, Parati G, Rarogli A. Twenty-four-hour blood pressure and antihypertensive treatment. Blood Press Suppl 1992;1:44-5.
18 Parati G, OMBONI S, Di Rienzo M, Frattola A, Albini F, Mancia G. Twenty-four hour blood pressure variability:clinical implications. Kidney Int Suppl 1992;37:S24-8.
19 Groppelli A, OMBONI S, Parati G, Mancia G. Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure. Hypertension 1992;2:227-32.
20 Trazzi S, OMBONI S, Santucciu C, Parati G, Mancia G. Variability in arterial diameter and compliance:compliance modulation reserve. J Hypertens Suppl 1992;6:S41-3.
21 Villani A, Parati G, Groppelli A, OMBONI S, Di Rienzo M, Mancia G. Noninvasive automatic blood pressure monitoring does not attenuate nighttime hypotension. Evidence from 24 h intraarterial blood pressure monitoring. Am J Hypertens 1992;10:744-7.
22 Mancia G, OMBONI S, Ravogli A, Frattola A, Villani A. Ambulatory blood pressure monitoring. Drugs 1992;1:17-22.
23 OMBONI S, Frattola A, Parati G, Ravogli A, Mancia G. Clinical value of blood pressure measurements:focus on ambulatory blood pressures. Am J Cardiol. 1992;12:4D-8D.
24 Mancia G, OMBONI S, Parati G, Trazzi S, Mutti E. Limited reproducibility of hourly blood pressure values obtained by ambulatory blood pressure monitoring:implications for studies on antihypertensive drugs. J Hypertens 1992;12:1531-5.
25 OMBONI S, Ravogli A, Mancia G. Ambulatory blood pressure monitoring and antihypertensive treatment. J Hum Hypertens 1992;2:S9-13.
26 Mancia G, Giannattasio C, OMBONI S. Ambulatory blood pressure monitoring and antihypertensive treatment. Eur Heart J 1992;G:43-7.
27 Mancia G, De Cesaris R, Fogari R, Lattuada S, Montemurro G, Palombo C, Porcellati C, Ranieri G, Tettamanti F, Verdecchia P, Marelli C, OMBONI S, Ravogli A, Zanchetti A, for the Italian Trandolapril Study Group. Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring. The Italian Trandolapril Study Group. Am J Cardiol 1992;70:60D-66D.
28 Laurent S, Hayoz D, Trazzi S, Boutouyrie P, Waeber B, OMBONI S, Brunner HR, Mancia G, Safar M. Isobaric compliance of the radial artery is increased in patients with essential hypertension. J Hypertens 1993;1:89-98.
29 Mancia G, OMBONI S, Parati G, Santucciu C, Trazzi S, Ulian L. Clinical value of ambulatory blood pressure monitoring. Am J Hypertens 1993;3 Pt 2:9S-13S.
30 Parati G, di Rienzo M, OMBONI S, Castiglioni P, Frattola A, Mancia G. Spectral analysis of 24 h blood pressure recordings. Am J Hypertens 1993;6 Pt 2:188S-193S.
31 Mancia G, OMBONI S, Parati G, Sega R, Trazzi S. Ambulatory blood pressure monitoring in the design of studies on antihypertensive drug efficacy. Am J Hypertens 1993;6 Pt 2:233S-235S.
32 OMBONI S, Parati G, Frattola A, Mutti E, Di Rienzo M, Castiglioni P, Mancia G. Spectral and sequence analysis of finger blood pressure variability. Comparison with analysis of intra-arterial recordings. Hypertension. 1993;1:26-33.

Zanchetti A, Bianchi L, Amigoni S, OMBONI S, Villani A, Ravogli A. Antihypertensive effects of nifedipine gastrointestinal therapeutic system on clinic and ambulatory blood pressure in essential hypertensives. Italian GITS Study Group. J Hypertens Suppl 1993;5:S334-5.
34 Pomidossi G, Saino A, Perondi R, Gregorini L, Alessio P, Rimini A, OMBONI S, Zanchetti A, Mancia G. Impairment of the arterial baroreflex during symptomatic and silent myocardial ischemia in humans. J Am Coll Cardiol 1993;7:1866-72.
35 Ravogli A, OMBONI S, De Cesaris R, Fogari R, Lattuada S, Montemurro G, Palombo C, Porcellati C, Ranieri G, Tettamanti C. Twenty-four-hour ambulatory blood pressure monitoring and antihypertensive treatment:focus on ACE inhibitors. J Cardiovasc Pharmacol 1994;1:S15-9.
36 Mancia G, OMBONI S, Parati G, Ravogli A, Sega R, Ulian L. Ambulatory blood pressure monitoring in the diagnosis of hypertension and evaluation of antihypertensive drug efficacy. Blood Press Suppl 1994;2:20-2.
37 Mancia G, Frattola A, Groppelli A, OMBONI S, Parati G, Ulian L, Villani A. Blood pressure reduction and end-organ damage in hypertension. J Hypertens Suppl 1994;8:S35-41.
38 Parati G, Ravogli A, Mutti E, Santucciu C, OMBONI S, Mancia G. Ambulatory blood pressure monitoring in the evaluation of antihypertensive drugs. J Hypertens Suppl 1994;8:S9-15.
39 OMBONI S, Smit AA, Wieling W. Twenty four hour continuous non-invasive finger blood pressure monitoring:a novel approach to the evaluation of treatment in patients with autonomic failure. Br Heart J 1995;3:290-2.
40 Mancia G, OMBONI S, Parati G, Ravogli A, Villani A, Zanchetti A. Lack of placebo effect on ambulatory blood pressure. Am J Hypertens 1995;3:311-5.
41 Mancia G, OMBONI S, Ravogli A, Parati G, Zanchetti A. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment:additional information from a large data base. Blood Press 1995;3:148-56.
42 Parati G, Di Rienzo M, OMBONI S, Ulian L, Mancia G. Blood pressure variability over 24 hours:its different components and its relationship to the arterial baroreflex. J Sleep Res 1995;S1:21-29.
43 Mancia G, Giannattasio C, Turrini D, Grassi G, OMBONI S. Structural cardiovascular alterations and blood pressure variability in human hypertension. J Hypertens Suppl 1995;2:S7-14.
44 OMBONI S, Parati G, Zanchetti A, Mancia G. Calculation of trough:peak ratio of antihypertensive treatment from ambulatory blood pressure:methodological aspects. J Hypertens 1995;10:1105-12.
45 OMBONI S, Ravogli A, Villani A, Mancia G. Permanent blood pressure control over the 24 h by trandolapril. Am J Hypertens 1995;10 Pt 2:71S-74S.
46 Thijs L, Dabrowska E, Clement D, Fagard R, Laks T, Mancia G, O'Brien E, OMBONI S, Parati G, Staessen J, et al. Diurnal blood pressure profile in older patients with isolated systolic hypertension. The SYST-EUR Investigators. J Hum Hypertens 1995;11:917-24.
47 Parati G, Ulian L, Santucciu C, OMBONI S, Mancia G. Blood pressure variability, cardiovascular risk and antihypertensive treatment. J Hypertens Suppl 1995;4:S27-34.
48 Ravogli A, Arzilli F, OMBONI S, Giovannetti R, Mutti E, Salvetti A, Mancia G. Lack of effect of percutaneous transluminal renal angioplasty on nocturnal hypotension in renovascular hypertensive patients. J Hypertens 1996;1:53-6.
49 Parati G, Frattola A, OMBONI S, Mancia G, Di Rienzo M. Analysis of heart rate and blood pressure variability in the assessment of autonomic regulation in arterial hypertension. Clin Sci (Lond) 1996;91 Suppl:129-32.
50 Mancia G, Parati G, OMBONI S, Ravogli A, Villani A, Santucciu C, Ulian L. Ambulatory blood pressure monitoring in the ELSA study. European Lacidipine Study on Atherosclerosis. Blood Press Suppl 1996;4:36-8.
51 Mancia G, OMBONI S. Ambulatory blood pressure, blood pressure variability and antihypertensive treatment. Clin Exp Hypertens. 1996;3-4:449-62.
52 Mancia G, OMBONI S, Parati G. Lessons to be learned from 24-hour ambulatory blood pressure monitoring. Kidney Int Suppl 1996;55:S63-8.
53 Parati G, OMBONI S, Mancia G. Difference between office and ambulatory blood pressure and response to antihypertensive treatment. J Hypertens. 1996;6:791-7.
54 OMBONI S, Parati G, Di Rienzo M, Wieling W, Mancia G. Blood pressure and heart rate variability in autonomic disorders:a critical review. Clin Auton Res 1996;3:171-82.
55 Mancia G, Gamba PL, OMBONI S, Paleari F, Parati G, Sega R, Zanchetti A. Ambulatory blood pressure monitoring. J Hypertens Suppl 1996;2:S61-6;discussion S66-8.
56 OMBONI S, Parati G, Groppelli A, Ulian L, Mancia G. Performance of the AM-5600 blood pressure monitor:comparison with ambulatory intra-arterial pressure. J Appl Physiol 1997;2:698-703.
57 Mancia G, OMBONI S, Parati G. Assessment of antihypertensive treatment by ambulatory blood pressure. J Hypertens Suppl 1997;2:S43-50.
58 Mancia G, OMBONI S, Grassi G. Combination treatment in hypertension:the VeraTran Study. Am J Hypertens 1997;7 Pt 2:153S-158S.
59 Zanchetti A, OMBONI S, Di Biagio C. Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension. J Hum Hypertens 1997;2:S57-9.
60 Baccelli G, Reggiani P, Mattioli A, Corbellini E, Garducci S, Catalano M, OMBONI S. Hemodynamic changes in the lower limbs during treadmill walking in normal subjects and in patients with arteriosclerosis obliterans. Angiology 1997;9:795-803.
61 Santucciu C, Parati G, Ulian L, OMBONI S, Mancia G. [The difference between clinical ambulatory measured blood pressure and daily monitored pressure does not reflect the "white coat effect"]. Cardiologia 1997;10:1067-9.
62 Parati G, OMBONI S, Staessen J, Thijs L, Fagard R, Ulian L, Mancia G. Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white-coat' effect. Syst-Eur investigators. J Hypertens 1998;1:23-9.
63 Mancia G, OMBONI S, Zanchetti A. Clinical advantages of lipophilic dihydropyridines. Blood Press Suppl. 1998;2:23-6.
64 Parati G, Ulian L, Santucciu C, OMBONI S, Mancia G. Difference between clinic and daytime blood pressure is not a measure of the white coat effect. Hypertension 1998;5:1185-9.
65 OMBONI S, Parati G, Palatini P, Vanasia A, Muiesan ML, Cuspidi C, Mancia G. Reproducibility and clinical value of nocturnal hypotension:prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens 1998;6:733-8.

OMBONI S, Parati G, Mancia G. The trough:peak ratio and the smoothness index in the evaluation of control of 24 h blood pressure by treatment in hypertension. Blood Press Monit 1998;3:201-204.
67 OMBONI S, Parati G, Castiglioni P, Di Rienzo M, Imholz BP, Langewouters GJ, Wesseling KH, Mancia G. Estimation of blood pressure variability from 24-hour ambulatory finger blood pressure. Hypertension 1998;1:52-8.
68 OMBONI S, Fogari R, Palatini P, Rappelli A, Mancia G. Reproducibility and clinical value of the trough-to-peak ratio of the antihypertensive effect:evidence from the sample study. Hypertension 1998;3:424-9.
69 Mancia G, Cattaneo BM, OMBONI S, Grassi G. Clinical benefits of a consistent reduction in blood pressure. J Hypertens Suppl 1998;6:S35-9.
70 Parati G, OMBONI S, Rizzoni D, Agabiti-Rosei E, Mancia G. The smoothness index:a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens 1998;11:1685-91.
71 OMBONI S, Zanchetti A. Antihypertensive efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements. Multicenter Study Investigators. J Hypertens 1998;12 Pt 1:1831-8.
72 Mancia G, Parati G, OMBONI S, Ulian L, Zanchetti A. Ambulatory blood pressure monitoring. Clin Exp Hypertens 1999;5-6:703-15.
73 Castiglioni P, Parati G, OMBONI S, Mancia G, Imholz BP, Wesseling KH, Di Rienzo M. Broad-band spectral analysis of 24 h continuous finger blood pressure:comparison with intra-arterial recordings. Clin Sci (Lond) 1999;2:129-39.
74 OMBONI S, Parati G, Mancia G. [Monitoring of blood pressure for 24 hours:historical, technical, and methodological features]. Cardiologia 1999;1(Pt 2):997-1000.
75 Parati G, OMBONI S, Mancia G. [Trough-peak ratio and the smoothness index in the assessment of duration and homogeneity of 24-hour antihypertensive effect]. Cardiologia 1999;1(Pt 1):345-8.
76 Mancia G, OMBONI S, Parati G. The importance of blood pressure variability in hypertension. Blood Press Monit 2000;1:S9-S15.
77 Mancia G, OMBONI S, Agabiti-Rosei E, Casati R, Fogari R, Leonetti G, Montemurro G, Nami R, Pessina AC, Pirrelli A, Zanchetti A. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients. J Cardiovasc Pharmacol 2000;6:926-31.
78 OMBONI S, Fogari R, Mancia G. A smooth blood pressure control is obtained over 24 h by delapril in mild to moderate essential hypertensives. Blood Press 2001;3:170-5.
79 Zanchetti A, OMBONI S. Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group. Am J Hypertens 2001;2:129-34.
80 Parati G, OMBONI S, Villani A, Glavina F, Castiglioni P, Di Rienzo M, Mancia G. Reproducibility of beat-by-beat blood pressure and heart rate variability. Blood Press Monit 2001;4:217-20.
81 Mancia G, OMBONI S, Parati G, Clement DL, Haley WE, Rahman SN, Hoogma RP. Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study. J Hypertens 2001;10:1755-63.
82 Zanchetti A, OMBONI S, La Commare P, De Cesaris R, Palatini P. Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension. J Cardiovasc Pharmacol 2001;4:642-50.
83 Mancia G, Parati G, Hennig M, Flatau B, OMBONI S, Glavina F, Costa B, Scherz R, Bond G, Zanchetti A;ELSA Investigators. Relation between blood pressure variability and carotid artery damage in hypertension:baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2001;11:1981-9.
84 OMBONI S, Smit AA, van Lieshout JJ, Settels JJ, Langewouters GJ, Wieling W. Mechanisms underlying the impairment in orthostatic tolerance after nocturnal recumbency in patients with autonomic failure. Clin Sci (Lond) 2001;6:609-18.
85 Antonicelli R, OMBONI S, Giovanni DC, Ansuini R, Mori A, Gesuita R, Parati G, Paciaroni E. Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring. Drugs Aging 2002;7:541-51.
86 Porcellati C, OMBONI S. Switching from ACE inhibitors, beta-blockers, calcium antagonists or diuretics to candesartan improves efficacy and tolerability. Blood Press 2002;5:310-9.
87 Mancia G, OMBONI S, Parati G;Investigators of the INSIGHT ABPM substudy. Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT). J Hypertens 2002;3:545-53.
88 Taddei S, OMBONI S, Ghiadoni L, Caiazza A, Fogari R, Innocenti P, Porcellati C, Giovannetti R, Corradi L, Mancia G, Salvetti A. Combination of lisinopril and nifedipine GITS increases blood pressure control compared with single drugs in essential hypertensive patients. J Cardiovasc Pharmacol 2003;4:579-85.
89 Mancia G, OMBONI S;CARDIO (CAndesaRtan combined with DIuretic in hypertensiOn) Study Group. Candesartan plus hydrochlorothiazide fixed combination vs previous monotherapy plus diuretic in poorly controlled essential hypertensive patients. Blood Press Suppl 2004;2:11-7.
90 Malacco E, Piazza S, OMBONI S;on behalf of the Zofenopril Study Group. Zofenopril versus Lisinopril in the Treatment of Essential Hypertension in Elderly Patients: A Randomised, Double-Blind, Multicentre Study. Clin Drug Investig 2005;3:175-182.
91 Mancia G, Parati G, Bilo G, Maronati A, OMBONI S, Baurecht H, Hennig M, Zanchetti A. Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure:data from the European Lacidipine Study on Atherosclerosis. J Hypertens 2007;5:1087-94.
92 Orzalesi N, Rossetti L, OMBONI S;OPTIME Study Group (Osservatorio sulla Patologia glaucomatosa, Indagine Medico Epidemiologica);CONPROSO (Collegio Nazionale dei Professori Ordinari di Scienze Oftalmologiche). Vascular risk factors in glaucoma:the results of a national survey. Graefes Arch Clin Exp Ophthalmol 2007;6:795-802.
93 Pini C, Pastori M, Baccheschi J, OMBONI S, Parati G;European Society of Hypertension. Validation of the Artsana CSI 610 automated blood pressure monitor in adults according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2007;3:179-84.
94 Bussone G, Tullo V, d'Onofrio F, Petretta V, Curone M, Frediani F, Tonini C, OMBONI S. Frovatriptan for the prevention of postdural puncture headache. Cephalalgia 2007;7:809-13.
95 OMBONI S, Riva I, Giglio A, Caldara G, Groppelli A, Parati G. Validation of the Omron M5-I, R5-I and HEM-907 automated blood pressure monitors in elderly individuals according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2007;4:233-42.

96. Malacco E, OMBONI S. Antihypertensive efficacy of zofenopril plus hydrochlorothiazide fixed combination for treatment in metabolic syndrome. Adv Ther 2007;5:1006-15.
97 Pecori Giraldi F, Toja PM, De Martin M, Maronati A, Scacchi M, OMBONI S,Cavagnini F, Parati G. Circadian blood pressure profile in patients with active Cushing's disease and after long-term cure. Horm Metab Res 2007;12:908-14.
98 Pini C, Natalizi A, Gerosa PF, Frigerio M, OMBONI S, Parati G. Validation of the Artsana CS 410 automated blood pressure monitor in adults according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2008;13:177-182.
99 OMBONI S, Costantini C, Pini C, Bulegato R, Manfellotto D, Rizzoni D, Palatini P, O'brien E, Parati G. PA.NET International Quality Certification Protocol for blood pressure monitors. Blood Press Monit 2008;13:285-289.
100 Parati G, OMBONI S, Palatini P, Rizzoni D, Bilo G, Valentini M, Agabiti-Rosei E, Mancia G. Italian Society of Hypertension Guidelines for Conventional and Automated Blood Pressure Measurement in the Office, at Home and Over 24 Hours. High Blood Pressure & Cardiovascular Prevention 2008;15:283-310.

More....

Research Interest: Cardiovascular Disease, Electrophysiology, Pacemaker, ICD and CRT Therapy, Metabolic Syndrome, Bidirectional Effect of CVD and CKD

Research Interest: It is Mainly Lies in Two Areas. First I Focused on Applying Statistical Methods and Multilevel Modeling in Randomized Clinical Trials and Family-Based Health-Related Interventions, Particularly in Substance Abuse, HIV/AIDS, STD, Sexual Risk Behaviors and Minority Health Disparities. Second, I am Interested in Epidemiology Studies 0f Chronic Disease Including Alcohol Use Disorder, Drug Abuse, Obesity, Diabetes, Metabolic Syndrome, Hypertension, Cardiovascular Disease and Stroke; and Also from Genetic Epidemiology Point of View to Examine Complex Disease Including Alcohol Dependence and Co-Morbidity, and Alzheimer Disease Etc. 

Research Interest: Deep Specialization in Research Involve; Obesity and Associated Disorder, Its Mechanism and Treatment. Metabolic Syndrome-Food Additives and Its Effect on the Bodyorgans. Also the Biochemical, Oxidative Stress and Advanced Biomarkers in Health and Diseases. Recently Involved in Nanomedical Materials as Antioxidant for Health Maintainance.

Dr. Mehta’s research program focuses on the role of innate immunity and inflammation in the development of cardiovascular and metabolic diseases. Using a trans-disciplinary approach that involves genetic epidemiology, translational medicine, and novel cardiovascular imaging approaches, Dr. Mehta and his team study how inflammation affects insulin resistance, the development of metabolic syndrome, and lipoprotein dysfunction, all of which are risk factors for atherosclerosis and subsequent cardiovascular disease (CVD).

Research Interest: Obesity, Chronic Hronic Inflammation, Inflammatory Disease, Cancer

Research Interest: Evaluation of biological activity of plant foods: anti-inflammatory, anti-glycation, anti-oxidant activities Influences of heat treatment on biological activity of foods.

List of Publications:

1.    Ho, Su-Chen, Chang, Yi-Huang, “Comparison of inhibitory capacities of 6-, 8- and 10-gingerols/shogaols on the canonical NLRP3 inflammasome-mediated IL-1β secretion” Molecules, Vol. 23, 2018, 02, p. 466.
2.    Ho, Su-Chen, Su, Min-Sheng, Lin, Chih- Cheng, Chiu, Chui-Feng, “Comparison of anti-glycation capacity of two new purple-colored-leaf tea cultivars with an ordinary green-colored-leaf tea cultivar in Taiwan,” Global Journal of Obesity, Diabetes and Metabolic Syndrome, Vol. 4, No. 1, 2017, 02, pp. 009-015.
3.    Yang, Tzu-Ting, Ho, Su-Chen, Chuang, Lu-Te, Chuang, Hsiao-Chi, Li, Ya-Ting, Wu, Jyun-Jie, “Characterization of particulate-phase polycyclic aromatic hydrocarbons emitted from incense burning and their bioreactivity in RAW264.7 macrophage,” Environmental Pollution, Vol. 220, 2017, 01, pp. 1190-1198.
4.    Ho, Su-Chen, Su, Min-Sheng, “Optimized heat treatment enhances the anti-inflammatory capacity of ginger “ International Journal of Food Properties, Vol. 19, 2016, pp. 1884-1898.
5.    Ho, Su-Chen, Su, Min-Sheng, “Evaluating the anti-neuroinflammatory capacity of raw and steamed garlic as well as five organosulfur compounds,” Molecules, Vol. 19, No. 11, 2014, pp. 17697-17714.
6.    Ho, Su-Chen, Kuo, Chun-Ting, “Hesperidin, Nobiletin, and Tangeretin Are Collectively Responsible for the Anti-neuroinflammatory Capacity of Tangerine Peel (Citri reticulatae pericarpium)” Food and Chemical Toxicology, Vol. 71, 2014, pp. 176-182.
7.    Ho, Su-Chen, Chang, Pei-Wen, Tong, Hui-Ting, Yu, Pin-Yuan, “Inhibition of Fluorescent Advanced Glycation End-products and N-carboxymethyllysine Formation by Several Floral Herbal Infusions,” International Journal of Food Properties, Vol. 17, 2014, pp. 617-628.
8.    Ho, Su-Chen, Su, Min-Sheng, Lin, Chih-Cheng, “Comparison of Peroxynitrite-Scavenging Capacities of Several Citrus Fruit Peels,” International Journal of Food Properties, Vol. 17, 2014, pp. 111-124.
9.    Ho, Su-Chen, Chang, Ku-Shang, Lin, Chih-Cheng, “Anti-neuroinflammatory Capacity of Fresh Ginger Is Attributed Mainly to 10-Gingerol,” Food Chemistry, Vol. 141, No. 3, 2013, 12, pp. 3183-3191.
10.    Ho, Su-Chen, Chang, Ku-Shang, Chang, Pei-Wen, “Inhibition of Neuroinflammation by Cinnamon and its Main Components,” Food Chemistry, Vol. 138, No. 4, 2013, pp. 2275-2282.
11.    Ho, Su-Chen, Chang, Pei-Wen, “Inhibitory Effects of Several Spices on Inflammation Caused by Advanced Glycation Endproducts,” American Journal of Plant Sciences, Vol. 3, No. 7, 2012, pp. 995-1002.
12.    Ho, Su-Chen, Wu, Szu-Pei, Lin, Shyh-Mirn, Tang, Ya-Li, “Comparison of Anti-glycation Capacities of Several Herbal Infusions with that of Green Tea,” Food Chemistry, Vol. 122, 2010, pp. 768-744.
13.    Lin, Shih-Min, Wang, Shih-Wei, Ho, Su-Chen, Tang, Ya-Li, “Protective Effect of Green Tea (-)-Epigallocatechin-3-gallate (EGCG) Against the Monoamine Oxidase B Enzyme Activity Increase in Adult Rat Brains,” Nutrition, Vol. 26, 2010, pp. 1195-1200.
14.    Huang, Yung-Sheng, Ho, Su-Chen, “Polymethoxy Flavones Are Responsible for the Anti-inflammatory Activity of Citrus Fruit Peel,”Food Chemistry, Vol. 119, 2010, pp. 868-873.
15.    Ho, Su-Chen, Tang, Ya-Li, Lin, Shih-Min, Liew, Yih-Fong, “Evaluation of Peroxynitrite-Scavenging Capacities of Several Commonly Used Fresh Spices,” Food Chemistry, Vol. 119, 2010, pp. 1102-1107.
16.    Ho, Su-Chen, Lin, Chih-Cheng, “Investigation of Heat Treating Conditions for Enhancing the Anti-inflammatory Activity of Citrus Fruit (Citrus reticulata) Peels,”Journal of Agricultural and Food Chemistry, Vol. 56, 2008, pp. 7976-7982.
17.    Lin, Chih-Cheng, Hung, Pi-Fong, Ho, Su-Chen, “Heat Treatment Enhances the NO-suppressing and Peroxynitrite-intercepting Activities of Kumquat’s (Fortunella margarita Swingle) Peel,”Food Chemistry, Vol. 109, 2008, pp. 95-103.
18.    Ho, Su-Chen, Tsai, Tzung-Hsun, Tsai, Po-Jung, Lin, Chih-Cheng, “Protective Capacities of Certain Spices Against Peroxynitrite-mediated Biomolecular Damage,”Food and Chemical Toxicology, Vol. 46, 2008, pp. 920-928.
19.    Ho, Su-Chen, Hwang, Lucy Sun, Shen, Yi-Jane, Lin, Chih-Cheng, “Suppressive Effect of a Proanthocyanidin-rich Extract from Longan (Dimocarpus longan Lour.) Flowers on Nitric Oxide Production in LPS-Stimulated Macrophage Cells,”Journal of Agricultural and Food Chemistry, Vol. 55, No. 26, 2007, pp. 10664-10670.
20.    Tsai, Po-Jung, Tsai, Tzung-Hsun, Ho, Su-Chen, “In vitro Inhibitory Effects of Rosemary Extracts on Growth and Glucosyltransferase Activity of Streptococcus sobrinus,” Food Chemistry, Vol. 105, 2007, pp. 311-316.
21.    Tsai, Po-Jung, Tsai, Tzung-Hsun, Yu, Chun-Hsien, Ho, Su-Chen, “Evaluation of NO-suppressing Activity of Several Mediterranean Culinary Spices,” Food and Chemical Toxicology, Vol. 45, 2007, pp. 440-447.
22.    Tsai, Po-Jung, Tsai, Tzung-Hsun, Yu, Chun-Hsien, Ho, Su-Chen, “Comparison of NO-scavenging and NO-suppressing Activities of Different Herbal Teas with those of Green Tea,” Food Chemistry, Vol. 103, 2007, pp. 181-187.
23.    Lin, Chih-Cheng, Lu, Min-Jer, Chen, Shen-Jen, Ho, Su-Chen, “Heavy Fermentation Impacts NO-Suppressing Activity of Tea in LPS-activated RAW 264.7 Macrophages,” Food Chemistry, Vol. 98, 2006, pp. 483-489.
24.    Tsai, Tzung-Hsun, Tsai, Po-Jung, Ho, Su-Chen, “Antioxidant and Antiinflammatory Activities of Several Commonly Used Spices,” Journal of Food Science, Vol. 70, No. 1, 2005, pp. pp. C93-C97.
25.    Tsai, Po-Jung, Yu, Chun-Hsien, Hsu SP, Lee YH, Huang IT, Ho, Su-Chen, Chu CH “Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: Negative association with gestational diabetes mellitus” Nutrition, Vol. 21, No. 11-12, 2005, pp.1095-9 •
26.    Tsai, Po-Jung, Ho, Su-Chen, Tsai LP, Lee YH, Hsu SP, Yang SP, Chu CH, Yu, Chun-Hsien, “Lack of relationship between beta3-adrenergic receptor gene polymorphism and gestational diabetes mellitus in a Taiwanese population” Metabolism, Vol. 53, No. 9, 2004, pp.1136-9.
27.    Tsai, Po-Jung, Yu, Chun-Hsien, Hsu SP, Lee YH, Chiou CH, Hsu YW, Ho, Su-Chen, Chu CH. “Cord plasma concentrations of adiponectin and leptin in healthy term neonates: positive correlation with birthweight and neonatal adiposity” Clin. Endocrinol. Vol. 61, 2004, pp. 88-93.
28.    Ho, Su-Chen, Tsai, Po-Jung, ”Comparison of the effects of "hot" and "cold" Chinese medicinal plants on the production of inflammatory mediators by RAW 264.7 cells” Journal of Food and Drug Analysis, Vol. 12, No. 2, 2004, pp. 120-127.

Research Interest: He has Vast Experience in Characterization of New Chemical Entities (NCE’S) for Early Stage Dosage form Development, Preparation of Nano Particles, Spray Dried Powders, Solubility Screening, Bio-Availability Enhancement, Granulation and Fluid Bed Drying, Compression Using Rotary Tablet Press, Coating, Stability Studies and Tech Transfer Etc.

Dr. Ahed J Alkhatib is currently working as a researcher in Department of Forensic Science and Toxicology, Jordan University of Sciences and Technology, Jordon from 2011 to till date. He completed his PhD in Campbell University, medical technology, North Carolina, USA from 2008 to 2011. Dr. Ahed J Alkhatib is a member of council of nutritional and environmental disease (CONEM). He is conducting research that generates new theories. Dr. Ahed J Alkhatib has done 116 Publications. He is establishing new science (molecular sociology).

Research Interest:  Neurology; Pharmacology; diabetes; Philosophy of science; Tumor research; Behavioral biology; Emergency medicine

List of Publications:

1-    Amro Saleem Falah Alamaren and Ahed J. Alkhatib (2019). The Relationship Between Financial Stability and Insurance. International Business Management, 13: 130-133.

2-    Ahed J Alkhatib (2019). Expression and Releasing of Cell Cycle Proteins by Candida albicans into Surrounding Tissue: New Perspectives of the Relationship between Microbes and Host. EC Microbiology, 15 (3): 168-171.

3-     Samirah Fahad A, Ahed Alkhatib (2019). The Assessment of Intervention Programs for Autism Including Children and their Parents. Am J Biomed Sci & Res., 1(6): 236-238. AJBSR.MS.ID.000553.

4-    Kawther Faisal Amawi, Inas Saleh Al-Mazari, Ali Alsarhan, Hamza Qasim Mohammad Alhamad, Ahed J. Alkhatib (2019). Diabetes upregulates the expression of HSP90 and downregulates HSP70 in the liver of diabetic rats. Comparative Clinical Pathology, 28 (2): 473-478.

5-    Ahed J. Alkhatib (2019). The Progression of a Disease Depends on Downregulation of Heat Shock Protein 70 (HSP70) And Upregulation of Inducible Nitric Oxide Synthase (iNOS): A New Medical Hypothesis. Biomed Discoveries: 1-3, DOI: 10.29011/ BMDC-103. 100003.

6-    Mohammad A. Bani-Ahmad, Suleimman A. Al-Sweedan, Mohammad A. Al-Asseiri, Ahed J. Alkhatib (2018). A Proposed Kinetic Model for the Diagnostic and Prognostic Value of WT1 and p53 in Acute Myeloid Leukemia. Clinical laboratory, 64 (3):357-363. doi: 10.7754/Clin.Lab.2017.170915.

7-    Ahed J Alkhatib, Ilham Ahed Alkhatib (2018). Metformin and Urtica pilulifera: Comparable Effects and Similar Actions in Diabetes. Int J Pharm,  8(3): 1-2.

8-    Ahed J Alkhatib (2018). White Matter Ageing: Etiology and Prognosis. Appl Cell Biol, 6 (2), 14-17.
 
9-    Khaled Z. Alawneh, Liqaa A. Raffee, Haytham A. Al Ewaidat and Ahed J. Alkhatib (2018).. The Impact of Exposure to Medical Radiation on Lead (Pb+2) and Thyroid Function Test. Research Journal of Medical Sciences, 12: 31-34.

10-    Hani A. Masaadeh, Ali Alrifai, Ahed J Alkhatib and Mamdoh Meqdam (2018). Molecular Epidemiology of Extended-Spectrum β-Lactamase-ProducingK. pneumoniae in Northern Jordan. Research Journal of Medical Sciences, 12: 63-69.

11-    Ahed J Alkhatib (2018). Does Epstein - Barr Virus Cross Talks with Sex Hormone Receptors on Lymphoid Cells Differently to Produce Lymphoma? Int J Pharm, 8(1): 56-57.

12-    Ahed J Alkhatib (2018). Non-classical Roles of Microbes.  PSM Microbiol., 3(2): 62-63.

13-    Sani S Bala, Ahed J Alkhatib, SS Bashir, Abdulhadi M (2018). Photocatalytic Degradation of Indigo Carmine in Aqueous Solutions by the Antibacterial Agent Pefloxacin and UVA. Biomed J Sci&Tech Res 5(5), DOI: 10.26717/ BJSTR.2018.05.001275.

14-    Sonia Cherian, Ahed J Alkhatib, Megha Aggarwal (2018). Relationship between organizational commitment and job satisfaction of nurses in Dubai hospital. Journal of Advances in Social Science and Humanities, 4(1): 36373-36400.

15-    Amro Saleem Falah Alamaren, Ahed J Alkhatib (2018). Financial Aspects Associated with Overuse of Health Resources. Biomed J Sci&Tech Res 7(1). BJSTR. MS.ID.001444. DOI: 10.26717/ BJSTR.2018.07.001444.

16-    Ahed J Alkhatib, Khalid Alzaailay (2018). The Appropriate Use of Activated Charcoal in Pharmaceutical and Toxicological Approaches. Biomed J Sci & Tech Res, 5 (2),

17-    Ahed J Alkatib (2017). Diabetes and diabetic neuropathies are independent events: a new medical hypothesis. Ind Res J Pharm & Sci, 4 (3): 1064-1067.


18-    Ahed J Alkhatib (2019). The Use of Crude Extract of Alhagi graecorum and Urtica pilulifera in the Treatment of Chronic Inflammation of Seminal Fluid: A Case Study. Open Acc J Comp & Alt Med 1(4): 62-64.

19-    Ahed J Alkhatib (2019). New Insights to Diabetes: Is Diabetes a Metabolic Disorder or a Neurological Disease? International Journal of Diabetes & Metabolic Disorders, 4 (1).

20-    Ahed J Alkhatib (2019). White Matter: Structural and Functional Roles in Health and Disease. PSM Biological Research, 4 (1): 17-19.

21-    Ahed J Alkhatib (2018). The role of natural antioxidants in declining memory defects in Alzheimer’s disease. J Spine Neurosurg, 7, DOI: 10.4172/2325-9701-C7-030.

22-    Alkhatib, A. J., (2018). Crude Extract of Potato Ameliorates Clinical Impacts of Infection with Helicobacter pylori: Case Study. PSM Microbiol. 3(2): 64-66.

23-    Ahed J Alkhatib (2018). It is time to change the concept of herbal use to molecular food. Ind Res J Pharm & Sci, 5 (4): 1648.

24-    Ahed J Alkhatib, Ilham Ahed Alkhatib, Kawther Faisal Amawi, Ali Alsarhan, Suha K Ababneh (2018). Sickle cell disease: molecular and pathophysiological features. Ind Res J Pharm & Sci, 5 (1), 1251-1259.

25-    Ahed J Alkhatib, Nayef Alzame (2018). Neurotoxicity and criminal behavior. Indian research journal of pharmacy and science, 5 (2): DOI: 1234-1238. 10.26717/BJSTR.2018.05.001170.

26-    Ahed J Alkhatib (2018). WHITE MATTER ASSOCIATED DISEASES.  Indian research journal of pharmacy and science, 5 (2): 1416-1419.

27-    Ahed J Alkhatib, Sani S. Bala, S.S. Bashir, Abdulhadi M (2018). Chemical and pharmaceutical properties of pefloxacin: a review. Indian research journal of pharmacy and science, 5 (2): 1427-1431.

28-    Mohamad M J Mohamad, Mustafa Al-Shehabat, Issa Ahmad AlShehabat, Ahed J Alkhatib (2018). The variations in altitude predict angiotensin ii and blood pressure variables in Jordan. Indian research journal of pharmacy and science, 5 (2): 1449-1455.


29-    Ahed J Alkhatib (2018). New Perspectives of Autoimmunity Diseases and Microbiome: Etiology and Treatment. Acta Scientific Pharmaceutical Sciences, 2(10): 12-14.

30-    Ahed J Alkhatib (2017). White Matter and Disease: Does Brain have a Role in Initiating Diseases. Brain Disorders & Therapy, 6: e124. doi: 10.4172/2168-975X.1000e124.

Research Interest: Nutrition, Weight management, Obesity Evaluation, Behavior Change Interventions, Critical Thinking, Health Disparity, Curriculum and Program Development, Type 2 Diabetes

Research Interest: Liver Cirrhosis, Gastrointestinal Diseases, Liver, Hepatitis, Chronic Hepatitis C, Cirrhosis, Bacteria, Virulence Factors, Cells